Answers are grounded in this paper and cite their sources.
Objective To investigate heart rate (HR) and rhythm, blood pressure (BP), and pupil diameter in dogs that received intracameral (IC) preservative-free lidocaine-epinephrine (ILE) as a sole mydriatic agent during phacoemulsification. Methods Records were retrospectively reviewed for HR and BP data and anesthesia concerns following administration of ILE during cataract surgery (IC group, 130 eyes from 83 dogs). Similar data were obtained for a control group undergoing phacoemulsification that received topical mydriatics (topical treatment [TT] group, 40 eyes from 21 dogs). Pupil diameter was measured prospectively following administration of ILE in an additional 20 eyes from 11 dogs. Results Average baseline HR was 13 beats/min higher in the TT group than in the IC group for both eyes operated ( P ≤ .04). Heart rate increased more from baseline in the IC group than in the TT group at 15 and 20 minutes after administration, but the difference was not clinically significant (average of 4 beats/min). Changes in BP were minimal and did not differ between groups. No significant arrhythmias or other anesthetic complications were noted in either group. Mean pupil diameter was 11.3 mm (95% CI, 11, 11.6) immediately following ILE administration and 11.8 mm (95% CI, 11.5, 12.1) at the conclusion of surgery. Conclusions ILE produced adequate, durable mydriasis when used as a sole mydriatic in canine eyes undergoing phacoemulsification. Intracameral lidocaine-epinephrine does not appear to affect cardiovascular parameters when administered during phacoemulsification in dogs. Clinical Relevance ILE is a reasonable mydriatic choice for canine phacoemulsification.
No takes yet. Share an insight, caveat, or question.
Pumphrey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: